Ricerca avanzata

Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2013 Giugno;32(3) > International Angiology 2013 Giugno;32(3):261-5



Rivista di Angiologia

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899

Periodicità: Bimestrale

ISSN 0392-9590

Online ISSN 1827-1839


International Angiology 2013 Giugno;32(3):261-5


Venous symptoms in C0 and C1 patients: UIP consensus document

Benigni J. P. 1, Bihari I. 2, Rabe E. 3, Uhl J. F. 4, Partsch H. 5, Cornu-Thenard A. 6, Jawien A. 7

1 HIA Bégin, Saint Mandé, France;
2 Semmelweis Egyetem, Egészségügyi Fôiskolai Kar, Klinikai Tanszék, Budapest, Hungary;
3 Department of Dermatology, University of Bonn, Bonn, Germany;
4 Vascular Surgeon, URDIA Research Unit EA4465, Université Paris Descartes, Paris, France;
5 Dermatology, University of Wien, Wien, Austria;
6 Hôpital Saint-Antoine, Paris, France;
7 Department of Surgery, Ludwik Rydygier University Medical School, Bydgoszcz, Poland

This UIP document provides an update on venous symptoms in CO and C1 patients. The correlation between venous symptoms and the presence of telangiectases and/or reticular veins is one of the most controversial topics in chronic venous disorders. As symptoms may be non-specific of chronic venous disease, it is important to differentiate venous symptoms from symptoms of other causes. Some data from the Bonn Vein Study suggest that the risk to develop venous symptoms is increased in women, advanced age and obesity. Treatment is based on physical advice, elastic compression, venoactive drugs, sclerotherapy, correction of foot static disorders and reduction of body weight. Future research should be promoted on venous symptoms in epidemiological and follow-up studies, about the relationship between female hormone levels and symptomatic telangiectasias, and between venous pain and foot static disorders in C0s C1s patients.

lingua: Inglese


inizio pagina